Also listed on Aventis Pharma S.A., an earlier holder on the record. The recorded assignments below show how it moved.
Term ended Nov 12, 2026 · High confidence
20-year base term ended Jan 27, 2023
Filed Jul 26, 2004 as application 10/898,754 · Granted Nov 3, 2009
Base term plus 1385 days of patent term adjustment (USPTO delay)
Today
Term ended Nov 12, 2026
2003
2026
Clock starts
Jan 27, 2003
Jan 27, 2003
Term ended
Nov 12, 2026
Nov 12, 2026
Granted
Nov 3, 2009
Nov 3, 2009
base term
patent term adjustment
after the term ends
fee events
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
1,385
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
2
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 1385 days past its 20-year base term on prosecution delay. All three maintenance fees were paid, so no fee lapse ended it. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jan 27, 2003, when application PCT/FR2003/000243, the earliest non-provisional in its chain, was filed (this one was filed Jul 26, 2004) | Jan 27, 2023 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +1385 days, USPTO patent term adjustment record | Nov 12, 2026 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | term ended | High confidence |
| Computed term end | The steps above, in order | Nov 12, 2026 | High confidence |
Partial family
| Application PCT/FR2003/000243 | PCT application no patent term | no patent term |
| US 7,612,087 | this patent Nov 2026 | Nov 2026 |
Partial: 1 of the 2 has no file history here, so its row comes from the patent's own record or names the application alone. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Sep 30, 2004 Reel 15204, frame 104 | Aszodi, Jozsef; Fromentin, Claude; Lampilas, Maxime; Rowlands, David Alan | Aventis Pharma S.A. | Assignment of Assignor's Interest |
| Nov 27, 2006 Reel 18545, frame 842 | Aventis Pharma S.A. | Novexel | Assignment of Assignor's Interest |
| May 24, 2011 Reel 26333, frame 38 | Novexel S. A. | Forest Laboratories Holdings Limited | Assignment of Assignor's Interest |
| May 17, 2023 Reel 63667, frame 581 | Forest Laboratories Holdings Limited | Forest Laboratories Holdings Unlimited Company | Change of Name |
| May 17, 2023 Reel 63667, frame 730 | Forest Laboratories Holdings Unlimited Company | Allergan Pharmaceuticals International Limited | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Note
The 1385 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
149
later US patents cite this one
That is top 5% of utility patents granted in 2009 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.